Welcome to Paid Research Studies




  • Condition:   Airway Inflammation
    Interventions:   Drug: Gamma Tocopherol;   Drug: Placebo
    Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Environmental Health Sciences (NIEHS)
    Recruiting

  • Conditions:   Erectile Dysfunction, CTCAE;   Impotence;   Prostate Adenocarcinoma
    Interventions:   Drug: Atorvastatin;   Drug: Pentoxifylline;   Dietary Supplement: Vitamin E Compound
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   NAFLD;   NASH - Nonalcoholic Steatohepatitis;   HIV Infections
    Interventions:   Drug: Vitamin E;   Drug: Placebos
    Sponsor:   Indiana University School of Medicine
    Recruiting

  • Conditions:   Diabetes;   Obesity;   Healthy Volunteers
    Interventions:   Drug: Alpha Toropherol (Vitamin E);   Dietary Supplement: Vitamin C
    Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Recruiting

  • Conditions:   End Stage Liver Disease;   Hepatitis C
    Interventions:   Dietary Supplement: Tocotrienol;   Other: Placebo
    Sponsors:   Indiana University;   Malaysia Palm Oil Board
    Recruiting

  • Conditions:   Medication-related Osteonecrosis of the Jaw;   Bisphosphonate-related Osteonecrosis of the Jaw;   Avascular Necrosis
    Interventions:   Drug: Pentoxifylline;   Drug: Placebo;   Drug: Tocopherol
    Sponsors:   University of Washington;   University of Alabama at Birmingham;   New York Center for Orthognathic and Maxillofacial Surgery;   Oregon Health and Science University;   University of Michigan
    Recruiting

  • Condition:   Ulcerative Colitis
    Interventions:   Dietary Supplement: Nutrition supplement;   Dietary Supplement: Placebo supplement
    Sponsor:   Baptist Memorial Health Care Corporation
    Recruiting

  • Condition:   Inflammation; Muscle
    Interventions:   Dietary Supplement: ESPO-572®;   Dietary Supplement: PCSO-524®
    Sponsor:   Indiana University
    Recruiting

  • Conditions:   Obesity;   Postmenopausal Women
    Interventions:   Drug: placebo softgel;   Drug: DeltaGold® Tocotrienol 70%
    Sponsor:   Texas Tech University Health Sciences Center
    Not yet recruiting

  • Conditions:   Dynapenia;   Postmenopausal Women
    Interventions:   Drug: placebo softgel;   Drug: DeltaGold® Tocotrienol 70%
    Sponsor:   Texas Tech University Health Sciences Center
    Not yet recruiting

  • Condition:   Keratoconus
    Interventions:   Other: Antioxidants (Vitamins A,C,E) plus GSH;   Other: Placebo;   Dietary Supplement: Centrum;   Combination Product: Dietary Sources
    Sponsors:   University of Miami;   Fight for Sight
    Not yet recruiting

  • Conditions:   Nutrient Deficiency;   Pregnancy Related
    Interventions:   Drug: Carotenoid Group;   Dietary Supplement: Control Group
    Sponsor:   Paul S. Bernstein
    Not yet recruiting

  • Condition:   Mental Health Disorders
    Interventions:   Dietary Supplement: PTSD/GAD Antioxidant;   Dietary Supplement: PTSD/GAD Placebo;   Dietary Supplement: Healthy Control Antioxidant;   Dietary Supplement: Healthy Control Placebo
    Sponsor:   Virginia Commonwealth University
    Recruiting

  • Conditions:   Degenerative Joint Disease;   Osteoarthritis;   Traumatic Arthritis
    Intervention:   Device: 3DKnee™ System with Vitamin E UHMWPE Tibial Inserts
    Sponsors:   Encore Medical, L.P.;   DJO Incorporated
    Recruiting

  • Condition:   Malignant Neoplasm
    Interventions:   Other: Interview;   Other: Questionnaire Administration
    Sponsor:   Wake Forest University Health Sciences
    Recruiting

  • Condition:   Surgical Site Infection
    Interventions:   Drug: Chlorhexidine Gluconate 2% Wipe;   Other: Theraworx Bath Wipes
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Condition:   Cancer of Pancreas
    Interventions:   Dietary Supplement: Nutrawell Powder;   Other: Diet Only;   Dietary Supplement: OmegaRich fish oil supplement
    Sponsor:   Jonsson Comprehensive Cancer Center
    Recruiting

  • Condition:   Diabetes Mellitus, Type 1
    Interventions:   Dietary Supplement: Antioxidant Cocktail;   Dietary Supplement: Resveratrol;   Other: Placebo
    Sponsors:   Augusta University;   National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

  • Condition:   Heart Failure With Reduced Ejection Fraction
    Interventions:   Dietary Supplement: Antioxidant;   Dietary Supplement: Tetrahydrobiopterin (BH4);   Other: Exercise training
    Sponsors:   VA Office of Research and Development;   University of Utah
    Recruiting

  • Conditions:   Avian Influenza;   Influenza Immunisation
    Interventions:   Biological: A/H7N9;   Drug: AS03;   Other: Phosphate Buffered Saline (PBS) diluent
    Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

  • Conditions:   Mucopolysaccharidosis Disorders;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Alpha-Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Glycoprotein Metabolic Disorders;   Sphingolipidoses;   Recessive Leukodystrophies;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann-Pick B;   Niemann-Pick C Subtype 2;   Sphingomyelin Deficiency;   Peroxisomal Disorders;   Adrenoleukodystrophy With Cerebral Involvement;   Zellweger Syndrome;   Neonatal Adrenoleukodystrophy;   Infantile Refsum Disease;   Acyl-CoA Oxidase Deficiency;   D-Bifunctional Enzyme Deficiency;   Multifunctional Enzyme Deficiency;   Alpha-methylacyl-CoA Racmase Deficiency;   Mitochondrial Neurogastrointestingal Encephalopathy;   Severe Osteopetrosis;   Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation);   Inherited Metabolic Disorders
    Interventions:   Biological: Stem Cell Transplantation;   Drug: IMD Preparative Regimen;   Drug: Osteopetrosis Only Preparative Regimen;   Drug: Osteopetrosis Haploidentical Only Preparative Regimen;   Drug: cALD SR-A (Standard-Risk, Regimen A);   Drug: cALD SR-B (Standard-Risk, Regimen B);   Drug: cALD HR-D (High-Risk, Regimen C);   Drug: cALD HR-D (High-Risk, Regimen D)
    Sponsor:   Masonic Cancer Center, University of Minnesota
    Recruiting

  • Conditions:   Medication-related Osteonecrosis of the Jaw;   Bisphosphonate-Associated Osteonecrosis of the Jaw
    Interventions:   Procedure: Conservative treatment;   Procedure: Surgical treatment;   Procedure: Adjuvant non-surgical treatment
    Sponsors:   AO Clinical Investigation and Documentation;   AOCMF
    Recruiting